Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.99 is 94% above its 5-year average of -16.84, near the high end of its 5-year range (-84.60–-0.99).
As of the fiscal period ended Wednesday, December 31, 2025. 71.75% above its 12-month average of -3.50.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
Reported annual fiscal-period values; no daily interpolation.
EARNINGS PER SHARE (EPS)
-0.99
EARNINGS PER SHARE (EPS) AVG TTM
-3.50
EARNINGS PER SHARE (EPS) AVG 3Y
-23.24
EARNINGS PER SHARE (EPS) AVG 5Y
-16.84
EARNINGS PER SHARE (EPS) AVG 10Y
-10.05
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+71.75%
CURRENT VS 3Y AVG
+95.74%
CURRENT VS 5Y AVG
+94.12%
CURRENT VS 10Y AVG
+90.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Teladoc Health, Inc.
Market Cap
$1.30B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$427.00M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$2.43B
Earnings Per Share (EPS)
-2.73
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$15.31M
Earnings Per Share (EPS)
-9.05
TTM Avg
-19.23
3Y Avg
-15.56
5Y Avg
-14.25
Market Cap
$2.90B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$7.05B
Earnings Per Share (EPS)
-0.09
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$7.23B
Earnings Per Share (EPS)
1.40
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$9.12B
Earnings Per Share (EPS)
-1.44
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.30B | -0.99 | -3.50 | -23.24 | -16.84 |
| NRC Health (NRC)vs › | $458.40M | 0.25 | 0.79 | 1.03 | 1.18 |
| Shoulder Innovations, Inc. (SI)vs › | $427.00M | -1.71 | -1.36 | -1.12 | -1.12 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.43B | -2.73 | -3.74 | -3.13 | -1.84 |
| 23andMe Holding Co. (ME)vs › | $15.31M | -9.05 | -19.23 | -15.56 | -14.25 |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 3.86 | 3.33 | 1.17 | 0.32 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.05B | -0.09 | 0.57 | 0.18 | -0.06 |
| Oscar Health, Inc. (OSCR)vs › | $7.23B | 1.40 | -0.79 | -1.41 | -1.76 |
| Tempus AI, Inc. (TEM)vs › | $9.12B | -1.44 | -3.00 | -2.43 | -2.16 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | 8.25 | -18.74 | -45.28 | 14.90 |
Trailing EPS (TTM)
$-0.99
Forward EPS (Est.)
$-0.87
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.14 |
| 2024-12-31 | -5.87 |
| 2023-12-31 | -1.36 |
| 2022-12-31 | -84.60 |
| 2021-12-31 | -2.73 |
| 2020-12-31 | -5.36 |
| 2019-12-31 | -1.38 |
| 2018-12-31 | -1.47 |
| 2017-12-31 | -1.93 |
| 2016-12-31 | -1.75 |
| 2015-12-31 | -2.91 |
| 2014-12-31 | -0.62 |
| 2013-12-31 | -0.22 |
